Syndromic Multiplex Diagnostic Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Syndromic Multiplex Diagnostic Market is Segmented by Type of Syndrome (Respiratory, Gastrointestinal, Neurological, and Others), End User and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >7.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The syndromic multiplex diagnostic market is anticipated to grow with a CAGR of nearly 7.2% during the forecast period. The major factors attributing to the growth of the syndromic multiplex diagnostic market include rise in the number of infectious cases and diseases and higher incidence of side effects associated with the use of antibiotics which demand proper diagnostics.

Thus, owing to its ability to address the rising needs of the patients and clinicians like utilization of lesser resources, enhanced accuracy of results are believed to lead the syndromic multiplex diagnostic market to grow throughout the forecast period. For instance, in May 2018, according to the World Health Organization, the leading cause of deaths recorded worldwide were lower respiratory infections necessitating the high requirement for advanced diagnostic equipment which fuel the global syndromic multiplex diagnostic market.

Scope of the Report

As per the scope of the treport, syndrome is a collection of abnormal signs and symptoms that are often associated with a specific disease where identification of the specific causative agent is difficult in order to take precautions in advance or give appropriate treatment for the patients. Syndromic multiplex diagnostic test employs testing of various pathogens in a single test reaction, helps healthcare providers to deliver efficient medications in proper time by minimizing uncertainty and mistakes that occur while testing of an infection. The syndromic multiplex diagnostic test gives more accurate, realistic and comprehensive result in critical care.

By Type of Syndrome
Central Nervous System
By End-user
Diagnostics Laboratories
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Respiratory Syndrome is Expected to Hold the Major Market Share in the Syndromic Multiplex Diagnostic Market

Respiratory syndromes account for the largest share of the syndromic multiplex diagnostics market and expected to continue the same throughout the forecast period. This dominance mainly due to factors such as the higher demand due to the rapid spread of infections along with the launch of new products with USFDA approvals in the segment that contributes to its major revenue share in the global market.

By End-user, hospitals account for the largest share due to the availability of all resources at a single facility. Also, the reduction of the overall stay of patients for treatment in hospitals with the reduced procedural time along with minimal or no uncertainties, and errors in the treatments is expected to fuel the market during the forecast period.

anti micr

North America Dominates the Market and Expected to do Same in the Forecast Period

North America has been the primary market for the syndromic multiplex diagnostic market and is expected to hold a significant share in global revenue owing to the adoption of advanced technologies and the availability of improved healthcare infrastructure, and also rise in R&D laboratories resultant.

Globally, the syndromic multiplex diagnostics market is expected to witness the fastest growth in Asia-Pacific region during the forecast period due to the higher demand for treatments with widespread infections, rise in government support to spread the healthcare awareness among people about various infections in the region.

syndromic multiplex diagnostic market

Competitive Landscape

The Global Syndromic multiplex diagnostic market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products, making acquisitions and partnerships to increase their footprints in the market. Some of the companies which are currently dominating the market are BIOMERIEUX SA, Luminex Corporation, QIAGEN, Applied BioCode, and Akonni Biosystems.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Accurate and Rapid Results

      2. 4.2.2 Quick Access to the Treatment and Reduction of the Adverse Reactions of Antibiotics

    3. 4.3 Market Restraints

      1. 4.3.1 Reluctance by Doctors and lack of Skilled Professional

      2. 4.3.2 Inability in Detecting Asymptomatic Cases

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type of Syndrome

      1. 5.1.1 Respiratory

      2. 5.1.2 Gastrointestinal

      3. 5.1.3 Central Nervous System

      4. 5.1.4 Others

    2. 5.2 By End-user

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostics Laboratories

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 BIOMERIEUX SA

      2. 6.1.2 Qiagen

      3. 6.1.3 Luminex Corporation

      4. 6.1.4 Applied BioCode

      5. 6.1.5 Akonni Biosystems

      6. 6.1.6 Mesa Biotech

      7. 6.1.7 Abbott Laboratories

      8. 6.1.8 Accelerate Diagnostic

      9. 6.1.9 Diagenode Diagnostics

      10. 6.1.10 Hologic, Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Syndromic Multiplex Diagnostic Market market is studied from 2018 - 2026.

The Syndromic Multiplex Diagnostic Market is growing at a CAGR of >7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Akonni Biosystems, Applied BioCode, QIAGEN, Luminex Corporation, BIOMERIEUX SA are the major companies operating in Syndromic Multiplex Diagnostic Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!